https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12621000964819
Clinical Trials
Modulating Auditory Symptoms and Vertigo of Meniere’s Disease by Non-invasive Mastoid Electric Stimulation
CATEGORY:
Clinical Trials
TITLE:
Modulating Auditory Symptoms and Vertigo of Meniere’s Disease by Non-invasive Mastoid Electric Stimulation
INTERVENTION/TREATMENT:
PHASE:
DESCRIPTION:
Condition : Meniere’s Disease
Interventions : Device: YPS-201b; Drug: betahistine
Sponsor : Seoul National University Hospital
Recruiting
ID:
NCT06001593
STATUS:
DATE – FIRST POSTED:
Mon, 21 Aug 2023 12:00:00 EDT
DATE – LAST UPDATE POSTED:
08/21/23 09:20AM
DATE – ADDED:
08/21/23 09:20AM
LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT06001593
LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT06001593
http://classic.clinicaltrials.gov/ct2/show/NCT06001593
REFERENCE:
Meniere’s Treatment Report, Urgent Research, 2023-08-21T13:20:25+00:00, https://www.menierestreatmentreport.com.
The CAVA Multicentre Dizziness Trial
CATEGORY:
Clinical Trials
TITLE:
The CAVA Multicentre Dizziness Trial
INTERVENTION/TREATMENT:
PHASE:
DESCRIPTION:
Conditions : Ménière’s Disease; Vestibular Migraine; Benign Paroxysmal Positional Vertigo (BPPV)
Intervention : Device: The continuous ambulatory vestibular assessment (CAVA) system
Sponsors : Norfolk and Norwich University Hospitals NHS Foundation Trust; University Hospitals, Leicester; St George’s University Hospitals NHS Foundation Trust; Gloucestershire Hospitals NHS Foundation Trust; University Hospital Birmingham NHS Foundation Trust; Mid and South Essex NHS Foundation Trust; Guy’s and St Thomas’ NHS Foundation Trust
Recruiting
ID:
NCT05984901
STATUS:
DATE – FIRST POSTED:
Wed, 09 Aug 2023 12:00:00 EDT
DATE – LAST UPDATE POSTED:
08/09/23 08:39AM
DATE – ADDED:
08/09/23 08:39AM
LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT05984901
LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT05984901
http://classic.clinicaltrials.gov/ct2/show/NCT05984901
REFERENCE:
Meniere’s Treatment Report, Urgent Research, 2023-08-09T12:39:40+00:00, https://www.menierestreatmentreport.com.
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
CATEGORY:
Clinical Trials
TITLE:
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
INTERVENTION/TREATMENT:
PHASE:
DESCRIPTION:
Conditions : Vertigo; BPPV; Meniere Disease; Labrynthitis; Vestibular Disorder; Vestibular Migraine; Benign Paroxysmal Positional Vertigo; Ménière’s Vertigo
Interventions : Device: Otoband Experimental; Device: Otoband Sham
Sponsors : Otolith Labs; MCRA
Recruiting
ID:
NCT05960786
STATUS:
DATE – FIRST POSTED:
Thu, 27 Jul 2023 12:00:00 EDT
DATE – LAST UPDATE POSTED:
07/27/23 09:11AM
DATE – ADDED:
07/27/23 09:11AM
LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT05960786
LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT05960786
http://classic.clinicaltrials.gov/ct2/show/NCT05960786
REFERENCE:
Meniere’s Treatment Report, Urgent Research, 2023-07-27T13:11:50+00:00, https://www.menierestreatmentreport.com.
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere’s Disease
https://clinicaltrials.gov/ct2/show/NCT04674735
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere’s Disease
Ménière’s Disease Registry (MDR) [Observational]
https://clinicaltrials.gov/ct2/show/NCT04438538
Go to sections
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Risk Factors for the Development of Bilateral Ménière’s Disease and the Establishment of a National Ménière’s Disease Registry.
Actual Study Start Date : June 20, 2020
Estimated Primary Completion Date : February 1, 2021
Estimated Study Completion Date : February 1, 2021
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere’s Disease
https://clinicaltrials.gov/ct2/show/NCT03664674
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere’s Disease
Previous update: October 10, 2019
Recent update: March 6, 2020
Updated on June 17, 2020 – new study location(s) added
A Study of a Mastoid Device in Subjects With Ménière’s Disease
https://clinicaltrials.gov/ct2/show/NCT03520322?type=Intr&cond=Meniere+Disease&lupd_s=01%2F29%2F2019&lupd_d=14
Condition : Meniere Disease
Interventions : Device: Mastoid Oscillator; Device: Control Device
Sponsor : University of Rochester
Enrolling by invitation
A Study of a Mastoid Device in Subjects With Ménière’s Disease
NCT03520322
Wed, 09 May 2018 12:00:00 EDT
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
https://clinicaltrials.gov/ct2/show/NCT04218123?type=Intr&cond=Meniere+Disease&lupd_s=12%2F23%2F2019&lupd_d=14
Condition : Meniere Disease
Interventions : Drug: Venlafaxine; Drug: Placebo oral tablet
Sponsors : Medical University of South Carolina; American Hearing Research Foundation
Not yet recruiting
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
NCT04218123
Mon, 06 Jan 2020 12:00:00 EST
SPI-1005 for the Treatment of Patients With Meniere’s Disease [Completed]
https://clinicaltrials.gov/ct2/show/NCT03325790?type=Intr&cond=Meniere+Disease&lupd_s=06%2F04%2F2019&lupd_d=14
Condition : Meniere’s Disease
Interventions : Drug: 200mg SPI-1005 BID; Drug: 400mg SPI-1005 BID; Other: Placebo
Sponsor : Sound Pharmaceuticals, Incorporated
Completed
SPI-1005 for the Treatment of Patients With Meniere’s Disease
NCT03325790
Mon, 30 Oct 2017 12:00:00 EDT
Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere’s Disease
https://clinicaltrials.gov/ct2/show/NCT03795675?type=Intr&cond=Meniere+Disease&lupd_s=02%2F28%2F2019&lupd_d=14
Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere’s Disease
Conditions : Vestibular Schwannoma; Meniere Disease
Intervention : Device: Cochlear Implant
Sponsors : Ohio State University; Advanced Bionics
Recruiting
CI Following VS Removal or Labyrinthectomy
NCT03795675
Tue, 08 Jan 2019 12:00:00 EST
Transcranial Vibrating System for Improving Vestibular Physical Therapy
https://clinicaltrials.gov/ct2/show/NCT03795168
Transcranial Vibrating System for Improving Vestibular Physical Therapy